Physician profile
Anna M Cooper
NPI 1043664972
$1,222.73
in general payments reported to CMS, 2019-2025
14 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.26 · 2022: $209 · 2023: $460 · 2024: $119 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $825 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.59 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $291.37 | 2023-2025 | Veozah |
| Abbvie INC. | $220.07 | 2021-2023 | |
| Daiichi Sankyo INC. | $131.55 | 2021-2022 | |
| Exeltis, USA INC. | $106.21 | 2023-2025 | Slynd |
| Mayne Pharma Commercial LLC | $105.73 | 2023 | |
| Pfizer INC. | $102.55 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $81.19 | 2023-2025 | |
| Organon LLC | $63.10 | 2022-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $34.69 | 2023 | Myosure Tissue Removal Device, Novasure |
| Axonics, INC. | $26.23 | 2023 | Axonics |
| Novo Nordisk INC | $17.77 | 2025 | Wegovy |
| Avion Pharmaceuticals | $15.93 | 2021 | |
| Shield Therapeutics INC | $14.03 | 2023 | Accrufer |
| Agile Therapeutics, INC. | $12.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.